Remote monitoring to manage nerve pain after chemotherapy
Part of Brain & nervous system, Cancer, Pain clinical trials.
This study tests whether remote check-ins (via phone/app/website) can help manage chemotherapy-related nerve pain in the hands and feet. It enrolls adults who developed nerve symptoms after certain cancer medicines and need ongoing monitoring.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older.
- Have finished (or are on) certain chemotherapy or related treatments within the last 540 days, or ongoing maintenance/survival/palliative treatment for more than 90 days.
- Have developed chemotherapy-related nerve damage (CIPN) during treatment or within 3 months after the last dose, affecting the same cancer treatment period.
- Have at least one nerve symptom that is rated moderate or severe on a 6-item symptom questionnaire (within the past week or on screening day).
- Be able to speak and read enough English to talk by phone and use the English-only app/website.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares doing rehabilitation exercises at home (via video calls) versus in a clinic to help relieve tingling, numbness, and pain in the hands and feet caused by chemotherapy. If you are a woman with breast cancer and have these nerve symptoms, this trial may help you find an effective way to manage them.
This study tests a diet program delivered online to help reduce nerve damage symptoms like numbness and tingling caused by chemotherapy. It is for cancer survivors who completed treatment and still have these symptoms.
This study looks at how chemotherapy that can affect nerves (“neurotoxic” chemo) changes nerve function over time. It may help researchers better measure nerve side effects and improve care for people who need these cancer treatments.
This study tests a non-invasive brain stimulation treatment to see if it can reduce nerve pain caused by chemotherapy. It also looks at how the treatment affects the brain and immune system.
This trial tests whether a spinal cord stimulator, a small device that sends gentle electrical signals to block pain, can relieve nerve pain caused by chemotherapy. If you have ongoing numbness or burning in your hands or feet after treatment, this study might help you feel better and improve your quality of life.
This study tests a new gel (VMD-3866) applied to the skin to treat moderate nerve pain, numbness, or tingling caused by previous chemotherapy. It aims to see if the gel can safely reduce pain for people whose symptoms have been stable for at least 8 weeks.
Hear when a new Chemotherapy-induced Peripheral Neuropathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.